Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when VNDA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsVanda stockholders approve equity plan expansion at 2026 annual meeting
Filed June 5, 2026 · Period ending June 4, 2026 · ~1 min read
Key Changes
-
medium
Stockholders approved expanding the 2016 Equity Incentive Plan share pool, increasing shares available for future employee and executive compensation grants. This provides management flexibility for talent retention but may dilute existing shareholders.
Item 5.07 verify on EDGAR → -
low
Three Class II directors elected to serve until 2029: Richard W. Dugan, Charles C. Duncan Ph.D., and Anne Sempowski Ward. All received majority stockholder support.
Item 5.07 verify on EDGAR → -
low
Say-on-pay vote passed with 91% approval (35.2M for vs 3.2M against), indicating stockholder support for executive compensation practices. Vote is advisory and non-binding.
Item 5.07 verify on EDGAR → -
low
PricewaterhouseCoopers LLP ratified as independent auditor for fiscal 2026 with 48.1M votes for, representing overwhelming approval of the audit committee's selection.
Item 5.07 verify on EDGAR →
Summary
Vanda Pharmaceuticals held its 2026 annual stockholder meeting on June 4, with the most material outcome being approval to expand the company's equity compensation plan. The amendment increases the share pool under the 2016 Equity Incentive Plan, giving management more stock-based compensation tools for recruiting and retaining talent.
While this provides operational flexibility, existing shareholders should be aware of potential dilution from future grants. The meeting otherwise proceeded routinely. Stockholders re-elected three directors to three-year terms, strongly endorsed executive pay practices with a 91% say-on-pay approval, and ratified the company's auditor.
These votes reflect typical annual meeting business with no surprises or contested items. Retail investors should watch for details on how the expanded equity pool will be used—specifically, the size and timing of future grants to executives and employees. The next proxy statement will reveal whether the additional shares lead to meaningful dilution or are deployed gradually over multiple years.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Vanda held its 2026 annual meeting; stockholders elected three Class II directors, ratified auditor, approved executive compensation, and approved equity plan expansion.
Added in current filing · verify on EDGAR →
The Company’s stockholders approved an amendment to the 2016 Plan to increase the aggregate number of shares authorized for issuance under the 2016 Plan.
Stockholders approved expanding the share pool under the 2016 Equity Incentive Plan with 31,729,991 votes for. This increases the number of shares available for future equity compensation grants to employees and executives, potentially diluting existing shareholders but providing the company flexibility for talent retention.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 8, 2026 · How we verify